The efficacy and safety of quinagolide in hyperprolactinemia treatment: A systematic review and meta-analysis

PURPOSE: Three dopamine agonists [bromocriptine, cabergoline, and quinagolide (CV)] have been used for hyperprolactinemia treatment for decades. Several studies have reviewed the efficacy and safety of bromocriptine and cabergoline. However, no systematic review or meta-analysis has discussed the ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Yanyang, Huang, Qingliang, Zou, Yunzhi, Tan, Jiacong, Zhou, Wu, Li, Meihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902948/
https://www.ncbi.nlm.nih.gov/pubmed/36761195
http://dx.doi.org/10.3389/fendo.2023.1027905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902948/
https://www.ncbi.nlm.nih.gov/pubmed/36761195
http://dx.doi.org/10.3389/fendo.2023.1027905

Ejemplares similares